|
WO2021044405A2
|
|
Therapeutic apoptotic cells for treatment of osteoarthritis
|
|
US2020289557A1
|
|
Early apoptotic cells for use in treating sepsis
|
|
WO2020105034A1
|
|
Early apoptotic cells for use treating sepsis
|
|
US2020121718A1
|
|
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
US2020061116A1
|
|
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
US2019083535A1
|
|
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
AU2018282127A1
|
|
Therapeutic apoptotic cells for cancer therapy
|
|
US2017360836A1
|
|
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
EP3416661A1
|
|
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
WO2016170541A1
|
|
Therapeutic pooled blood apoptotic cell preparations and uses thereof
|
|
CN107530376A
|
|
Combined immunization therapy and cell factor control therapy for treatment of cancer
|
|
IL239236D0
|
|
Therapeutic apoptotic cell preparations, method for producing same and uses thereof
|
|
CA2893962A1
|
|
Therapeutic apoptotic cell preparations, method for producing same and uses thereof
|
|
EP1879601A1
|
|
Disease therapy using dying or dead cells
|
